HemoSonics

QUANTRA® HEMOSTASIS SYSTEM WITH QSTAT® CARTRIDGE

Critically bleeding patients need targeted therapy-fast.

Hemosonics-Qstat-logo
The fully sealed, room-temperature stable cartridge performs multiple tests simultaneously
Qstat Cartridge Test Parameters9
The fully sealed, room-temperature stable cartridge performs multiple tests simultaneously
Qstat Cartridge Test Parameters9
Results in 15 minutes or less1,4
Complete results in 25-60 minutes or less1,4,9
Hemosonics-Quantra-unit
Hemosonics-Quantra-logo
The ultrasound-based Quantra® System is now the only cartridge-based whole blood hemostasis analyzer indicated by the FDA for cardiovascular and major orthopedic surgeries-and is now cleared, with the addition of the QStat Cartridge, for use in trauma and liver transplantation-making Quantra a truly comprehensive solution for bleeding management.1
Now, you can easily standardize across multiple locations to help optimize blood product usage.

Dials Display

Easy to learn and adopt system-wide
After only 30 minutes of training, new users were able to read and interpret results of QStat Dials display with >97% proficiency8
Provides quick confirmation of clot lysis1,4,9
The QStat Cartridge directly compares changes in clot stiffness in both the presence and absence of tranexamic acid, automatically correcting for clot retraction caused by interaction between platelets/fibrin and the measuring device.
Intuitive by Design
Dials Display
Intuitive display makes it simple to identify coagulopathies
Curves Display
Observe clot time/stiffness curves developing in real time
Trends Display
Easily observe trends in patient status over time

HOW TO ORDER

Please contact your local sales representative for pricing and ordering information.
System Component Ref. #
Quantra Hemostasis Analyzer HS-002
QPlus® Cartridge, Kit of 10 KT-0004
QStat Cartridge, Kit of 10 KT-0020
QPlus Control Level 1, Kit of 4 (Lyophilized 2-8 C) KT-0023
QPlus Control Level 2, Kit of 4 (Lyophilized 2-8 C) KT-0025
System Component Ref. #
QStat Control Level 1, Kit of 4 (Lyophilized 2-8 C) KT-0027
QStat Control Level 2, Kit of 4 (Lyophilized 2-8 C) KT-0032
Cleaning Cartridge, Kit of 10 KT-0012
Quantra Printer KT-0015
Quantra Desktop Remote Viewer, Software KT-0039
System Component Ref. #
Quantra Hemostasis Analyzer HS-002
QPlus® Cartridge, Kit of 10 KT-0004
QStat Cartridge, Kit of 10 KT-0020
QPlus Control Level 1, Kit of 4 (Lyophilized 2-8 C) KT-0023
QPlus Control Level 2, Kit of 4 (Lyophilized 2-8 C) KT-0025
QStat Control Level 1, Kit of 4 (Lyophilized 2-8 C) HS-0027
QStat Control Level 2, Kit of 4 (Lyophilized 2-8 C) KT-0032
Cleaning Cartridge, Kit of 10 KT-0012
Quantra Printer KT-0015
Quantra Desktop Remote Viewer, Software KT-0039
For a full listing of the instrument features, configurations, specifications, and parts, please contact HemoSonics, LLC.
Indications for Use
The QStat Cartridge is a multi-channel cartridge that provides semi-quantitative indications of the coagulation and clot lysis state of a 3.2% citrated venous whole blood sample using the Quantra® Hemostasis Analyzer. The QStat Cartridge includes tests to assess coagulation via the intrinsic and extrinsic pathways and includes a test with tranexamic acid to evaluate clot lysis characteristics.
The QStat Cartridge is intended for in vitro diagnostic use by trained professionals at the point-of-care and in clinical laboratories to evaluate the viscoelastic properties of whole blood by means of the following functional parameters: Clot Time (CT), Clot Stiffness (CS), Fibrinogen Contribution to Clot Stiffness (FCS), Platelet Contribution to Clot Stiffness (PCS), and Clot Stability to Lysis (CSL).
The QStat Cartridge is indicated for the evaluation of blood coagulation and clot lysis in patients age 18 years and older to assess possible hypocoagulable and hypercoagulable conditions in trauma and liver transplantation procedures.
Results obtained with the QStat Cartridge should not be the sole basis for patient diagnosis.
For prescription use only.
References: 1. Quantra® Hemostasis Analyzer User Manual. 2020. HemoSonics, LLC. 2. Baulig W, Akbas S, Schütt PK, et al. Comparison of the resonance sonorheometry based Quantra® system with rotational thromboelastometry ROTEM® sigma in cardiac surgery – a prospective observational study. BMC Anesthesiol. 2021;21(1):260. 3. Idowu O, Ifeanyi-Pillette I, Owusu-Agyemang P, et al. The quantra hemostasis analyzer compared to thromboelastography (TEG) in the surgical oncologic population: a prospective observational trial. J Surg Oncol. 2021;124(5):894-905. 4. Michelson EA, Cripps MW, Ray B, Winegar DA, Viola F. Initial clinical experience with the Quantra QStat System in adult trauma patients. Trauma Surg Acute Care Open. 2020;5(1):e000581. 5. Groves DS, Welsby IJ, Naik BI, et al. Multicenter evaluation of the Quantra QPlus System in adult patients undergoing major surgical procedures. Anesth Analg. 2020;130(4):899-909. 6. Winegar DA, Viola F. Is the Quantra QPlus system easy to interpret? American Association of Clinical Chemistry (AACC) Annual Scientific Meeting, Virtual Congress, December 13-17, 2020. 7. Winegar DA, Gillespie C, Sanchez-Illan M. Improving the Interpretation of Viscoelastic Test Results in the Critical Care Setting. Reader Study Abstract. American Association of Clinical Chemistry (AACC) Conference, July 2022. 8. Leadbetter NH, Givens TB, Viola F. Unique approach to quality assurance in viscoelastic testing. J Appl Lab Med. 2020;5(6):1228-1241. 9. QStat Cartridge Instructions for Use (IFU). HemoSonics, LLC.